{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:03:38Z","timestamp":1790629418988,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/N\/NZ2\/04267"],"award-info":[{"award-number":["2015\/17\/N\/NZ2\/04267"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2014\/15\/B\/NZ1\/00490"],"award-info":[{"award-number":["UMO-2014\/15\/B\/NZ1\/00490"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11011-018-0308-1","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T02:35:54Z","timestamp":1534473354000},"page":"2005-2017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington\u2019s disease patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Paulina","family":"J\u0119drak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Mozolewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":false,"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz R.","family":"Wi\u0119ckowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"308_CR1","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Y\u00e9benez JG, Boesiger P, Weindl A, Maguire RP (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain 119:2085\u20132095","journal-title":"Brain"},{"key":"308_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R, Mart\u00edn MA, Rubio JC, Ablanedo P, Cabello A (1998) Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol 43:397\u2013400. \n                    https:\/\/doi.org\/10.1002\/ana.410430321","journal-title":"Ann Neurol"},{"key":"308_CR3","volume-title":"Huntington\u2019s disease","author":"G Bates","year":"2002","unstructured":"Bates G, Harper PJL (2002) Huntington\u2019s disease, 3rd edn. Oxford University press, Oxford","edition":"3"},{"key":"308_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/J.PSYCHRES.2010.04.030","volume":"178","author":"LJ Beglinger","year":"2010","unstructured":"Beglinger LJ, O\u2019Rourke JJF, Wang C et al (2010) Earliest functional declines in Huntington disease. Psychiatry Res 178:414\u2013418. \n                    https:\/\/doi.org\/10.1016\/J.PSYCHRES.2010.04.030","journal-title":"Psychiatry Res"},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis. Ann N Y Acad Sci 1147:358\u2013382. \n                    https:\/\/doi.org\/10.1196\/annals.1427.018","journal-title":"Ann N Y Acad Sci"},{"key":"308_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U et al (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653. \n                    https:\/\/doi.org\/10.1002\/ana.410410514","journal-title":"Ann Neurol"},{"key":"308_CR7","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4:28\u201337","journal-title":"Psychiatry (Edgmont)"},{"key":"308_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1373\/49.8.1309","volume":"49","author":"B Chabi","year":"2003","unstructured":"Chabi B, Mousson De Camaret B, Duborjal H et al (2003) Quantification of mitochondrial DNA deletion, depletion, and overreplication: application to diagnosis. Clin Chem 49:1309\u20131317. \n                    https:\/\/doi.org\/10.1373\/49.8.1309","journal-title":"Clin Chem"},{"key":"308_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3969\/j.issn.1673-5374.2012.05.009","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regen Res 7:376\u2013385. \n                    https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.05.009","journal-title":"Neural Regen Res"},{"key":"308_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","volume":"45","author":"M-C Chiang","year":"2012","unstructured":"Chiang M-C, Chern Y, Huang R-N (2012) PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease. Neurobiol Dis 45:322\u2013328. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.08.016","journal-title":"Neurobiol Dis"},{"key":"308_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s11064-006-9110-2","volume":"31","author":"P Hoyo del","year":"2006","unstructured":"del Hoyo P, Garc\u00eda-Redondo A, de Bustos F, Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, Arenas J, Jim\u00e9nez-Jim\u00e9nez FJ (2006) Oxidative stress in skin fibroblasts cultures of patients with Huntington\u2019s disease. Neurochem Res 31:1103\u20131109. \n                    https:\/\/doi.org\/10.1007\/s11064-006-9110-2","journal-title":"Neurochem Res"},{"key":"308_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","volume":"59","author":"L Djouss\u00e9","year":"2002","unstructured":"Djouss\u00e9 L, Knowlton B, Cupples LA et al (2002) Weight loss in early stage of Huntington\u2019s disease. Neurology 59:1325\u20131330","journal-title":"Neurology"},{"key":"308_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00415-011-6104-z","volume":"258","author":"M Filosto","year":"2011","unstructured":"Filosto M, Scarpelli M, Cotelli MS, Vielmi V, Todeschini A, Gregorelli V, Tonin P, Tomelleri G, Padovani A (2011) The role of mitochondria in neurodegenerative diseases. J Neurol 258:1763\u20131774. \n                    https:\/\/doi.org\/10.1007\/s00415-011-6104-z","journal-title":"J Neurol"},{"key":"308_CR14","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","volume":"273","author":"WJJ Firdaus","year":"2006","unstructured":"Firdaus WJJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J 273:5428\u20135441. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05537.x","journal-title":"FEBS J"},{"key":"308_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF, Wheeler VC, Persichetti F, MacDonald M (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12:497\u2013508","journal-title":"Hum Mol Genet"},{"key":"308_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash M, Mann VM (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385\u2013389. \n                    https:\/\/doi.org\/10.1002\/ana.410390317","journal-title":"Ann Neurol"},{"key":"308_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1006\/exnr.2000.7626","volume":"169","author":"P Guidetti","year":"2001","unstructured":"Guidetti P, Charles V, Chen E-Y, Reddy PH, Kordower JH, Whetsell WO Jr, Schwarcz R, Tagle DA (2001) Early degenerative changes in transgenic mice expressing mutant Huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp Neurol 169:340\u2013350. \n                    https:\/\/doi.org\/10.1006\/exnr.2000.7626","journal-title":"Exp Neurol"},{"key":"308_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306:234\u2013238","journal-title":"Nature"},{"key":"308_CR19","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1523\/JNEUROSCI.18-19-07674.1998","volume":"18","author":"CA Gutekunst","year":"1998","unstructured":"Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM (1998) The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J Neurosci 18:7674\u20137686","journal-title":"J Neurosci"},{"key":"308_CR20","doi-asserted-by":"publisher","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","volume":"286","author":"S Hands","year":"2011","unstructured":"Hands S, Sajjad MU, Newton MJ, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286:44512\u201344520. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.307587","journal-title":"J Biol Chem"},{"key":"308_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes P, Wanker EE, Bates G et al (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28:425\u2013433. \n                    https:\/\/doi.org\/10.1016\/S0968-0004(03)00168-3","journal-title":"Trends Biochem Sci"},{"key":"308_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"308_CR23","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s11011-017-0026-0","volume":"32","author":"P J\u0119drak","year":"2017","unstructured":"J\u0119drak P, Krygier M, To\u0144ska K, Drozd M, Kaliszewska M, Bartnik E, So\u0142tan W, Sitek EJ, Stanis\u0142awska-Sachadyn A, Limon J, S\u0142awek J, W\u0119grzyn G, Bara\u0144ska S (2017) Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts. Metab Brain Dis 32:1237\u20131247. \n                    https:\/\/doi.org\/10.1007\/s11011-017-0026-0","journal-title":"Metab Brain Dis"},{"key":"308_CR24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"308_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","volume":"1822","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Antioxidants in Huntington\u2019s disease. Biochim Biophys Acta 1822:664\u2013674. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2011.11.014","journal-title":"Biochim Biophys Acta"},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","volume":"52","author":"B Kalyanaraman","year":"2012","unstructured":"Kalyanaraman B, Darley-Usmar V, Davies KJA, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ II, Ischiropoulos H (2012) Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med 52:1\u20136. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.09.030","journal-title":"Free Radic Biol Med"},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin ZH, Chen JD, Nevins JR, Aronin N, DiFiglia M (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476. \n                    https:\/\/doi.org\/10.1074\/jbc.M103946200","journal-title":"J Biol Chem"},{"key":"308_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.410120504","volume":"12","author":"DE Kuhl","year":"1982","unstructured":"Kuhl DE, Phelps ME, Markham CH, Metter EJ, Riege WH, Winter J (1982) Cerebral metabolism and atrophy in huntington\u2019s disease determined by18FDG and computed tomographic scan. Ann Neurol 12:425\u2013434. \n                    https:\/\/doi.org\/10.1002\/ana.410120504","journal-title":"Ann Neurol"},{"key":"308_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"S-H Li","year":"2004","unstructured":"Li S-H, Li X-J, Zoghbi H et al (2004) Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20:146\u2013154. \n                    https:\/\/doi.org\/10.1016\/j.tig.2004.01.008","journal-title":"Trends Genet"},{"key":"308_CR30","first-page":"84","volume":"3","author":"M Manatt","year":"2011","unstructured":"Manatt M, Chandra SB (2011) The effects of mitochondrial dysfunction in schizophrenia. J Med Genet Genomics 3:84\u201394","journal-title":"J Med Genet Genomics"},{"key":"308_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2013.11.014","volume":"337","author":"E Marchina","year":"2014","unstructured":"Marchina E, Misasi S, Bozzato A, Ferraboli S, Agosti C, Rozzini L, Borsani G, Barlati S, Padovani A (2014) Gene expression profile in fibroblasts of Huntington\u2019s disease patients and controls. J Neurol Sci 337:42\u201346. \n                    https:\/\/doi.org\/10.1016\/j.jns.2013.11.014","journal-title":"J Neurol Sci"},{"key":"308_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","volume":"45","author":"RP Mason","year":"2013","unstructured":"Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease. Nat Genet 45:1249\u20131254. \n                    https:\/\/doi.org\/10.1038\/ng.2732","journal-title":"Nat Genet"},{"key":"308_CR33","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","volume":"2","author":"F Mochel","year":"2007","unstructured":"Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, le Bouc Y, Gervais C, Carcelain G, Vassault A, Feingold J, Rabier D, Durr A (2007) Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2:e647. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0000647","journal-title":"PLoS One"},{"key":"308_CR34","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang C-E, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0106-08.2008","journal-title":"J Neurosci"},{"key":"308_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst C-A, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736. \n                    https:\/\/doi.org\/10.1038\/nn884","journal-title":"Nat Neurosci"},{"key":"308_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","volume":"40","author":"WD Parker","year":"1990","unstructured":"Parker WD, Boyson SJ, Luder AS, Parks JK (1990) Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington\u2019s disease. Neurology 40:1231\u20131234","journal-title":"Neurology"},{"key":"308_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mito.2014.05.001","volume":"17","author":"MH Petersen","year":"2014","unstructured":"Petersen MH, Budtz-J\u00f8rgensen E, S\u00f8rensen SA, Nielsen JE, Hjermind LE, Vinther-Jensen T, Nielsen SMB, N\u00f8rrem\u00f8lle A (2014) Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington\u2019s disease. Mitochondrion 17:14\u201321. \n                    https:\/\/doi.org\/10.1016\/j.mito.2014.05.001","journal-title":"Mitochondrion"},{"key":"308_CR38","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11011-018-0214-6","volume":"33","author":"K Pierzynowska","year":"2018","unstructured":"Pierzynowska K, Gaffke L, Cyske Z, Puchalski M, Rintz E, Bartkowski M, Osiad\u0142y M, Pierzynowski M, Mantej J, Piotrowska E, W\u0119grzyn G (2018a) Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases. Metab Brain Dis 33:989\u20131008. \n                    https:\/\/doi.org\/10.1007\/s11011-018-0214-6","journal-title":"Metab Brain Dis"},{"key":"308_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12017-018-8482-1","volume":"20","author":"K Pierzynowska","year":"2018","unstructured":"Pierzynowska K, Gaffke L, Ha\u0107 A, Mantej J, Niedzia\u0142ek N, Brokowska J, W\u0119grzyn G (2018b) Correction of Huntington\u2019s disease phenotype by genistein-induced autophagy in the cellular model. NeuroMolecular Med 20:112\u2013123. \n                    https:\/\/doi.org\/10.1007\/s12017-018-8482-1","journal-title":"NeuroMolecular Med"},{"key":"308_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2007.04.008","volume":"27","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Haas RH, Le T et al (2007) Normal platelet mitochondrial complex I activity in Huntington\u2019s disease. Neurobiol Dis 27:99\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2007.04.008","journal-title":"Neurobiol Dis"},{"key":"308_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JTJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684\u2013697. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4001511","journal-title":"Mol Psychiatry"},{"key":"308_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27:1083\u20131091. \n                    https:\/\/doi.org\/10.1002\/mds.25075","journal-title":"Mov Disord"},{"key":"308_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","volume":"80","author":"RA Quintanilla","year":"2009","unstructured":"Quintanilla RA, Johnson GVW (2009) Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease. Brain Res Bull 80:242\u2013247. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2009.07.010","journal-title":"Brain Res Bull"},{"key":"308_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.NEUBIOREV.2014.11.005","volume":"48","author":"A Rajasekaran","year":"2015","unstructured":"Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M (2015) Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 48:10\u201321. \n                    https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2014.11.005","journal-title":"Neurosci Biobehav Rev"},{"key":"308_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"PH Reddy","year":"2009","unstructured":"Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Res Rev 61:33\u201348. \n                    https:\/\/doi.org\/10.1016\/j.brainresrev.2009.04.001","journal-title":"Brain Res Rev"},{"key":"308_CR46","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/J.FREERADBIOMED.2012.09.004","volume":"53","author":"M Ribeiro","year":"2012","unstructured":"Ribeiro M, Rosenstock TR, Cunha-Oliveira T, Ferreira IL, Oliveira CR, Rego AC (2012) Glutathione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 53:1857\u20131867. \n                    https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2012.09.004","journal-title":"Free Radic Biol Med"},{"key":"308_CR47","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nprot.2008.56","volume":"3","author":"KM Robinson","year":"2008","unstructured":"Robinson KM, Janes MS, Beckman JS (2008) The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 3:941\u2013947. \n                    https:\/\/doi.org\/10.1038\/nprot.2008.56","journal-title":"Nat Protoc"},{"key":"308_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. \n                    https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"308_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A (2009) Huntington\u2019s disease: the current state of research with peripheral tissues. Exp Neurol 219:385\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2009.05.012","journal-title":"Exp Neurol"},{"key":"308_CR50","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson MA, Gusella JF, Laramie JM, Myers RH, Lesort M, MacDonald ME (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14:2871\u20132880. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddi319","journal-title":"Hum Mol Genet"},{"key":"308_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA (1995) Widespread expression of Huntington\u2019s disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"308_CR52","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"SH Snyder","year":"1999","unstructured":"Snyder SH, Sawa A, Wiegand GW et al (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194\u20131198. \n                    https:\/\/doi.org\/10.1038\/13518","journal-title":"Nat Med"},{"key":"308_CR53","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, TRACK-HD investigators (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(09)70170-X","journal-title":"Lancet Neurol"},{"key":"308_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"308_CR55","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/mds.21540","volume":"22","author":"C Turner","year":"2007","unstructured":"Turner C, Cooper JM, Schapira AHV (2007) Clinical correlates of mitochondrial function in Huntington\u2019s disease muscle. Mov Disord 22:1715\u20131721. \n                    https:\/\/doi.org\/10.1002\/mds.21540","journal-title":"Mov Disord"},{"key":"308_CR56","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/hmg\/dds516","volume":"22","author":"A Valencia","year":"2013","unstructured":"Valencia A, Sapp E, Kimm JS, McClory H, Reeves PB, Alexander J, Ansong KA, Masso N, Frosch MP, Kegel KB, Li X, DiFiglia M (2013) Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington\u2019s disease. Hum Mol Genet 22:1112\u20131131. \n                    https:\/\/doi.org\/10.1093\/hmg\/dds516","journal-title":"Hum Mol Genet"},{"key":"308_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang H, Lim PJ, Karbowski M, Monteiro MJ (2009) Effects of overexpression of Huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18:737\u2013752. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddn404","journal-title":"Hum Mol Genet"},{"key":"308_CR58","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta 1842:1240\u20131247. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.015","journal-title":"Biochim Biophys Acta"},{"key":"308_CR59","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2010.01.028","volume":"48","author":"J Zielonka","year":"2010","unstructured":"Zielonka J, Kalyanaraman B (2010) Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 48:983\u20131001. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.01.028","journal-title":"Free Radic Biol Med"},{"key":"308_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nprot.2007.473","volume":"3","author":"J Zielonka","year":"2008","unstructured":"Zielonka J, Vasquez-Vivar J, Kalyanaraman B (2008) Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat Protoc 3:8\u201321. \n                    https:\/\/doi.org\/10.1038\/nprot.2007.473","journal-title":"Nat Protoc"},{"key":"308_CR61","doi-asserted-by":"publisher","unstructured":"Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M (2014) Skeletal muscle pathology in Huntington\u2019s disease. 5:380. \n                    https:\/\/doi.org\/10.3389\/fphys.2014.00380","DOI":"10.3389\/fphys.2014.00380"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0308-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T15:01:57Z","timestamp":1569337317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0308-1","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}